Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Herren Wu

A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

Cancer Cell

English

A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

English

Development of an Antibody That Neutralizes Soluble IgE and Eliminates IgE Expressing B Cells

Cellular and Molecular Immunology

English

Structural Insights Into Neonatal Fc Receptor-Based Recycling Mechanisms

Journal of Biological Chemistry

English

Targeted Drug Delivery via Caveolae-Associated Protein PV1 Improves Lung Fibrosis

Communications Biology

English

Regulation of Antibody-Mediated Complement-Dependent Cytotoxicity by Modulating the Intrinsic Affinity and Binding Valency of IgG for Target Antigen

English

Design and Characterization of Homogenous Antibody-Drug Conjugates With a Drug-To-Antibody Ratio of One Prepared Using an Engineered Antibody and a Dual-Maleimide Pyrrolobenzodiazepine Dimer

English

Fab-Arm Exchange Combined With Selective Protein a Purification Results in a Platform for Rapid Preparation of Monovalent Bispecific Antibodies Directly From Culture Media

Pharmaceutics

Pharmaceutical Science

2019

English

Crystallization and Preliminary X-Ray Diffraction Analysis of the Complex Between a Human Anti-Alpha Toxin Antibody Fragment and Alpha Toxin

Acta Crystallographica Section F Structural Biology and Crystallization Communications

2013

English

Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)

Journal of Biological Chemistry

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Herren Wu

A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

Development of an Antibody That Neutralizes Soluble IgE and Eliminates IgE Expressing B Cells

Structural Insights Into Neonatal Fc Receptor-Based Recycling Mechanisms

Targeted Drug Delivery via Caveolae-Associated Protein PV1 Improves Lung Fibrosis

Regulation of Antibody-Mediated Complement-Dependent Cytotoxicity by Modulating the Intrinsic Affinity and Binding Valency of IgG for Target Antigen

Design and Characterization of Homogenous Antibody-Drug Conjugates With a Drug-To-Antibody Ratio of One Prepared Using an Engineered Antibody and a Dual-Maleimide Pyrrolobenzodiazepine Dimer

Fab-Arm Exchange Combined With Selective Protein a Purification Results in a Platform for Rapid Preparation of Monovalent Bispecific Antibodies Directly From Culture Media

Crystallization and Preliminary X-Ray Diffraction Analysis of the Complex Between a Human Anti-Alpha Toxin Antibody Fragment and Alpha Toxin

Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)